Rapid clearance of bacteria and their toxins: Development of therapeutic proteins

Critical Reviews in Immunology

Volumn 27, Issue 3, 2007, Pages 233-245

  Kunkel, Meghan ^a   Vuyisich, Momchilo ^a   Gnanakaran, Gnana ^b   Bruening, George E ^c   Dandekar, Abhaya M ^c   Civerolo, Edwin ^d   Marchalonis, John J ^e   Gupta, Goutam ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Antimicrobials; Chimera; Pathogens; Toxins

Indexed keywords

ALPHA DEFENSIN; ALPHA DEFENSIN 1; ALPHA DEFENSIN 2; ALPHA DEFENSIN 3; AZITHROMYCIN; BACTERIAL TOXIN; BETA DEFENSIN; BETA DEFENSIN 3; CECROPIN; CECROPIN B; CEPHALOSPORIN DERIVATIVE; CHIMERIC PROTEIN; COLLECTIN LIVER 1; COLLECTIN OF 43 KDA; COLLECTIN OF 46 KDA; COLLECTIN PLACENTA 1; CONGLUTININ; DEFENSIN; IMIPENEM; LECTIN; MANNAN BINDING LECTIN; MANNOSE BINDING PROTEIN; MEMBRANE PROTEIN; METALLOPROTEINASE; PROTEIN MOPB; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; UNINDEXED DRUG; VON WILLEBRAND FACTOR;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIGEN SPECIFICITY; BACILLUS ANTHRACIS; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; SALMONELLA; SALMONELLOSIS; STAPHYLOCOCCUS AUREUS; XYLELLA FASTIDIOSA;

EID: 38049065141     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v27.i3.40     Document Type: Conference Paper

References (38)

1. Rottner K, Stradal TE, Wehland J. Bacteria-host-cell interactions at the plasma membrane: stories on actin cytoskeleton subversion. Dev Cell. 2005;9:3-17.
2. Plant L, Jonsson AB. Contacting the host: insights and implications of pathogenic Neisseria cell interactions. Scand J Infect Dis. 2003;35:608-13.
3. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev. 1997;61:136-69.
4. Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99-166.
5. Mollhoff M, Zanden HB, Shiflett PR, Gupta G. Modeling of receptor mimics that inhibit superantigen pathogenesis. J Mol Recognit. 2005;181:73-83.
6. Hong-Geller E, Mollhoff M, Shiflett PR, Gupta G. Design of chimeric receptor mimics with different TcRVbeta isoforms. Type-specific inhibition of superantigen pathogenesis. J Biol Chem. 2004;279:5676-84.
7. Dandekar AM, Gupta G, Hong-Geller E, McDonald K. Design of chimeric antimicrobial proteins for rapid clearance of xylella. Pierce's Disease Symposium Proceedings; 2004 Dec; Pierce's Disease Board; 2004. p. 233-6.
8. Lehnert NM, Allen DL, Allen BL, Catasti P, Shiflett PR, Chen M, Lehnert BE, Gupta G. Structure-based design of a bispecific receptor mimic that inhibits T cell responses to a superantigen. Biochemistry. 2001;40:4222-8.
9. Jack DL, Klein NJ, Turner MW. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev. 2001;180:86-99.
10. Fujita T, Matsushita M, Endo Y. The lectin-complement pathway - its role in innate immunity and evolution. Immunol Rev. 2004;198:185-202.
11. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SPD: structure, function and receptors. Mol Immunol. 2006;43:1293-315.
12. McArthur JD, Walker MJ. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development. Mol Microbiol. 2006;59:1-4.
13. Alcorn JF, Wright JR. Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune function. J Biol Chem. 2004;279:30871-9
14. Zabel BA, Zuniga L, Ohyama T, Allen SJ, Cichy J, Handel TM, Butcher EC. Chemoattractants, extracellular proteases, and the integrated host defense response. Exp Hematol. 2006;34:1021-32.
15. Renckens R, Roelofs JJ, Florquin S, de Vos AF, Lijnen HR, van't Veer C, van der Poll T. Matrix metalloproteinase-9 deficiency impairs host defense against abdominal sepsis. J Immunol. 2006;176:3735-41.
16. Armstrong PB. Proteases and protease inhibitors: a balance of activities in host-pathogen interaction. Immunobiology. 2006;211:263-81
17. Lehrer RI, Ganz T. Defensins of vertebrate animals. Curr Opin Immunol. 2002;14:96-102
18. De Smet K, Contreras R. Human anti-microbial peptides: defensins, cathelicidins and histatins. Biotechnol Lett. 2005;27:1337-47.
19. Munk C, Wei G, Yang OO, Waring AJ, Wang W, Hong T, Lehrer RI, Landau NR, Cole AM. The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses. 2003;19:875-81.
20. Chen H, Xu Z, Peng L, Fang X, Yin X, Xu N, Cen P. Recent advances in the research and development of human defensins. Peptides. 2006;27:931-40.
21. Pelegrini PB, Franco OL. Plant gamma-thionins: novel insights on the mechanism of action of a multi-functional class of defense proteins. Int J Biochem Cell Biol. 2005;37:2239-53.
22. Lay FT, Anderson MA. Defensins - components of the innate immune system in plants. Curr Protein Pept Sci. 2005;6:85-101.
23. Bulet P, Stocklin R. Insect anti-microbial peptides: structures, properties and gene regulation. Protein Pept Lett. 2005;12:3-11.
24. Tan YT, Tillett DJ, McKay IA. Molecular strategies for overcoming antibiotic resistance in bacteria. Mol Med Today. 2000;6:309-14.
25. Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and anti-microbial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother. 2004;48:4800-7.
26. Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A. MprF-mediated biosynthesis of lysyl-phosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett. 2004;231:67-71.
27. Rooijakkers SH, van Kessel KP, van Strijp JA. Staphylococcal innate immune evasion. Trends Microbiol. 2005;13:596-601.
28. Shi Y, Cromie MJ, Hsu FF, Turk J, Groisman EA. PhoP-regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B. Mol Microbiol. 2004;53:229-41.
29. Moskowitz SM, Ernst RK, Miller SI. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol. 2004;186:575-9.
30. Lambais MR, Goldman MH, Camargo LE, Goldman GH. A genomic approach to the understanding of Xylella fastidiosa pathogenicity. Curr Opin Microbiol. 2000;3:459-62.
31. Bruening GE, Civerolo EL, Feldstein P, Franscis, M, Dandekar AM, Gupta, G. Exploiting xylella fastidiosa proteins for Pierce's disease control. Research Symposium PD and GWSS; 2005; Book of Abstracts; Pierce's Disease Board. p. 221-5.
32. Stoycheva MV, Murdjeva MA. Anti-microbial therapy of salmonelloses - current state and perspectives. Folia Med (Plovdiv). 2006;48:5-10.
33. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006 368:874-85.
34. Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol. 2004;7:19-24.
35. Hecht G. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position. Am J Physiol Gastrointest Liver Physiol. 2001;281:G1-7.
36. Caya JG. Clostridium botulinum and the ophthalmologist: a review of botulism, including biological warfare ramifications of botulinum toxin. Surv Ophthalmol. 2001;46:25-34.
37. Scobie HM, Rainey GJ, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci U S A. 2003;100(9):5170-4.
38. Santelli E, Bankston LA, Leppla SH, Liddington RC. Crystal structure of a complex between anthrax toxin and its host cell receptor. Nature. 2004;430:905-8.